Pharmafile Logo

News and Press Releases

Moderna Receives MHRA Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1

The LP.8.1 vaccine is the first commercially licenced mRNA vaccine to be manufactured in the UK at the Moderna Innovation and Technology Centre in Oxfordshire The updated vaccines will be...

Category: Biotechnology, Drug Delivery, Drug Discovery, Other, Pharmaceutical
Posted: February 10, 2026

Moderna
info@modernatx.com
Global Headquarters 200 Technology Square Cambridge, MA 02139

Data from GNT-018-IDES trial supports feasibility of imlifidase as pretreatment in gene therapy treatment for patients with Crigler–Najjar syndrome who are immune to AAV

Results presented today at ESGCT 2025 10 October 2025 -- Paris, France and Lund, Sweden -- Genethon, a worldwide pioneer and leader in research and development of gene therapy for rare...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: October 10, 2025

Genethon
1 bis, rue de l’Internationale 91000 EVRY-COURCOURONNES

Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination

Companies sign definitive agreement following previously announced binding term sheet Transaction to create an expanded, SIX-listed, commercial-stage, AI-driven, scalable health tech company Combined company to be renamed MindMaze Therapeutics Holding...

Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: October 8, 2025

Relief Therapeutics
contact@relieftherapeutics.com
Avenue de Sécheron 15 1202 Geneva Switzerland

Clinigen to Acquire SSI Strategy, Charting a Seamless Path from Clinical Strategy to Global Commercialisation for Biotech Innovators

29 September 2025 -- London, UK -- Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle, today announced it has entered into a definitive agreement to...

Category: Biotechnology, Logistics, Other, Pharmaceutical
Posted: September 29, 2025

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH

Terumo Blood and Cell Technologies Supports Expanded Access to Rare Disease Therapies in Latin America  

Regulatory approvals in 14 countries expand treatment options for sickle cell disease, Guillain-Barré syndrome and myasthenia gravis Approvals align with the historic World Health Assembly resolution on rare diseases. 16...

Category: Biotechnology, Drug Delivery, Other, Pharmaceutical
Posted: September 16, 2025

Terumo Blood and Cell Technologies
Old Belfast Road Millbrook Larne BT40 2SH

Rilzabrutinib granted orphan drug designation in the US for two rare diseases with no approved medicines

Designation granted for warm autoimmune hemolytic anemia and IgG4-related disease Rilzabrutinib is currently under regulatory review in the US, EU and China for potential use in immune thrombocytopenia.  3 April...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 3, 2025

Sanofi
One Onslow Street, Guildford, Surrey, GU1 4YS, UK

Clinigen collaborates with Servier to expand access to specialised oncology and haematology medicines in South Africa

17 March 2025 -- London, UK -- Clinigen, the global speciality pharmaceutical services group, today announced that Equity Pharmaceuticals, part of the Clinigen Group, has entered into a new collaboration...

Category: Drug Delivery, Other, Pharmaceutical
Posted: March 17, 2025

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH

Clinigen Announces Strategic Partnership with Tepsivo

Expanding Client Choice with AI-Powered Pharmacovigilance Solutions 27 January 2025 -- London, UK -- Clinigen, the global specialist pharmaceutical services company, today announced a strategic partnership with Tepsivo, a pioneering...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: January 27, 2025

Clinigen
25 Bedford Square Bloomsbury London WC1B 3HH

PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics

14 January 2025 – Menlo Park, California US – PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud University Medical Center...

Category:
Posted: January 16, 2025

PacBio
support@pacb.com
1305 O’Brien Drive Menlo Park, CA 94025

Santhera Enters into Supply and Distribution Agreement for AGAMREE (Vamorolone) with Clinigen Group

6 January 2025 -- Pratteln, Switzerland -- Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE (vamorolone) in countries...

Category: Logistics, Manufacturing and Packing, Other, Pharmaceutical
Posted: January 6, 2025

Santhera
office@santhera.com
Santhera Pharmaceuticals Headquarters Hohenrainstrasse 24 | 4133 Pratteln | Switzerland

PTC Therapeutics to Participate at Upcoming Investor Conferences

4 November 2024 -- New Jersey, US -- PTC Therapeutics, Inc today announced that the company will present a company overview at the following conferences: UBS Global Healthcare ConferenceWednesday, Nov....

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 4, 2024

PTC Therapeutics
info@ptcbio.com
PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449

Sterling Pharma Solutions Announces Partnership with Soligenix for the Manufacture of Oncology-Targeted API

3 October 2024 -- Cramlington, UK -- Sterling Pharma Solutions, a global contract development and manufacturing organisation, and Soligenix, a late-stage biopharmaceutical company focused on developing and commercialisation of products...

Category: BioManufacturing, Clinical Trials, Pharmaceutical
Posted: October 3, 2024

Sterling Pharma Solutions
enquiries@sterlingpsl.com
Sterling Place, Dudley Cramlington, Northumberland, NE23 7QG, United Kingdom

AzurBio Pharma Launches to Fast-Track European Market Entry for Biopharma Companies with Breakthrough Treatments

1 October 2024 -- Paris, France -- AzurBio Pharma, specializing in bringing innovative pharmaceutical products to European markets and focusing on rare and serious diseases with unmet medical needs, is...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 1, 2024

AzurBio Pharma
32 Av. Kléber, 75116 Paris, France

Sarepta Therapeutics Announces Recipients of LGMD Grant Awards for 2024; Program Supports Early Genetic Testing and Awareness

Recipients awarded a total of more than $100,000 in grants Funding will support education and activities to shorten diagnostic journey. 30 September 2024 -- Massachusetts, US -- Sarepta Therapeutics, Inc, the...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 30, 2024

Sarepta Therapeutics
tsorrentino@sarepta.com
Hill House, 1 Little New Street London, EC4A 3TR United Kingdom

Mogrify appoints Dr Jonathan Appleby as chief scientific officer

Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024

Mogrify
info@mogrify.co.uk
25 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0FW